Researchers conducted a study to determine whether integrase strand transfer inhibitor-based antiretroviral therapy is associated with lipid changes in patients with HIV infection.
Researchers sought to identify which medications for type 2 diabetes may be associated with severity of COVID-19.
Admission-blood glucose is strong predictor of death among patients admitted directly to the intensive care unit.
Patients with hyperglycemia and COVID-19 had higher cumulative probability of mortality.
Study authors assess the association between statin therapy and in-hospital mortality in patients with COVID-19 and concomitant diabetes mellitus.
Study authors assessed various demographic, HIV-specific, and antiretroviral-therapy-specific risk factors associated with weight gain following initiation of antiretroviral therapy in patients with HIV.
This study found that diabetic patients with COVID-19 had lower lymphocyte counts and hospital stays.
Treatment with sitagliptin had no effect on soluble CD14 when given to participants with virally suppressed HIV infection.
Switching from a protease inhibitor to raltegravir or dolutegravir was effective in improving insulin sensitivity, and reduced lipid parameters in PLWHIV.
